Preventive effect of enalapril on erythrocytosis after renal transplantation.
Rhee
S R
SR
Department of Surgery, Internal Medicine and Physiology, Chonbuk National University Medical School, Chonju, Korea.
Park
S K
SK
Kang
S K
SK
Kim
S H
SH
Cho
B H
BH
Kim
J H
JH
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use; D004656:Enalapril / Q000009:adverse effects / Q000627:therapeutic use*; D004921:Erythropoietin / Q000097:blood; D005260:Female; D006400:Hematocrit; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D009543:Nifedipine / Q000009:adverse effects / Q000627:therapeutic use; D011086:Polycythemia / Q000517:prevention & control*; D011183:Postoperative Complications; D012189:Retrospective Studies; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D004921:Erythropoietin; D004656:Enalapril; D009543:Nifedipine